- Report
- September 2023
- 110 Pages
Spain
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 115 Pages
Portugal
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 27 Pages
Canada
From €825EUR$926USD£727GBP
- Report
- September 2023
- 26 Pages
Colombia
From €825EUR$926USD£727GBP
From €825EUR$926USD£727GBP
- Report
- September 2023
- 101 Pages
Vietnam
From €2200EUR$2,470USD£1,939GBP
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 99 Pages
China
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 114 Pages
Norway
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 109 Pages
Canada
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 100 Pages
Argentina
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 108 Pages
Greece
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 101 Pages
Denmark
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 78 Pages
Croatia
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 122 Pages
France
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 119 Pages
Italy
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 105 Pages
Colombia
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 105 Pages
Netherlands
From €2200EUR$2,470USD£1,939GBP
- Report
- September 2023
- 56 Pages
Jordan
From €1675EUR$1,881USD£1,476GBP
- Report
- September 2023
- 110 Pages
United Kingdom
From €2200EUR$2,470USD£1,939GBP
Allergic Rhinitis is a condition that affects the nose and is caused by an allergic reaction to certain substances. Over the Counter (OTC) drugs are used to treat the symptoms of Allergic Rhinitis, such as sneezing, runny nose, and itchy eyes. OTC drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. Common active ingredients in OTC drugs for Allergic Rhinitis include antihistamines, decongestants, and corticosteroids. These drugs can be used to reduce inflammation, relieve congestion, and reduce the severity of symptoms.
Some companies in the Allergic Rhinitis Drug market include Johnson & Johnson, GlaxoSmithKline, Novartis, Merck, and Sanofi. Show Less Read more